ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 016,51
0,30%
Dow Jones
38 686,32
1,51%
DAX
18 628,80
0,79%
Brent Oil
81,195
0,48%
Bitcoin
69 109,52
2,01%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Precipio Inc (PRPO)

  7. Precipio Inc (PRPO) Actualités

PRPO

Precipio (PRPO)

Precipio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRPO
DateHeureSourceTitreSymboleSociété
14/05/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPOPrecipio Inc
06/05/202423h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
06/05/202423h00GlobeNewswire Inc.Precipio Secures a short-term $500K Credit FacilityNASDAQ:PRPOPrecipio Inc
25/03/202422h00GlobeNewswire Inc.Precipio Announces Year end 2023 Shareholder Update CallNASDAQ:PRPOPrecipio Inc
13/02/202416h00GlobeNewswire Inc.Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoYNASDAQ:PRPOPrecipio Inc
06/02/202416h00GlobeNewswire Inc.Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for CancerNASDAQ:PRPOPrecipio Inc
23/01/202416h00GlobeNewswire Inc.Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarterNASDAQ:PRPOPrecipio Inc
19/01/202422h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRPOPrecipio Inc
17/01/202416h30GlobeNewswire Inc.Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in JapanNASDAQ:PRPOPrecipio Inc
04/01/202422h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
04/01/202422h30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
02/01/202415h00GlobeNewswire Inc.Precipio Announces Christina Valauri joins the Board of DirectorsNASDAQ:PRPOPrecipio Inc
14/12/202322h30GlobeNewswire Inc.Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024NASDAQ:PRPOPrecipio Inc
16/11/202323h00GlobeNewswire Inc.Precipio Announces Q3-2023 Shareholder Update CallNASDAQ:PRPOPrecipio Inc
18/10/202315h00GlobeNewswire Inc.Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022NASDAQ:PRPOPrecipio Inc
03/10/202316h00GlobeNewswire Inc.Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023NASDAQ:PRPOPrecipio Inc
28/09/202315h00GlobeNewswire Inc.Precipio Continues to Sign New HemeScreen™ CustomersNASDAQ:PRPOPrecipio Inc
25/09/202317h00GlobeNewswire Inc.Precipio Reduces Product Revenue Result Needed for Cash Flow BreakevenNASDAQ:PRPOPrecipio Inc
13/09/202315h30GlobeNewswire Inc.Precipio’s Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of PlanNASDAQ:PRPOPrecipio Inc
10/08/202323h00GlobeNewswire Inc.Precipio Announces Q2-2023 Shareholder Update CallNASDAQ:PRPOPrecipio Inc
08/08/202315h00GlobeNewswire Inc.Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 PanelNASDAQ:PRPOPrecipio Inc
03/08/202315h00GlobeNewswire Inc.Precipio’s Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards BreakevenNASDAQ:PRPOPrecipio Inc
01/08/202315h00GlobeNewswire Inc.Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023NASDAQ:PRPOPrecipio Inc
20/07/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRPOPrecipio Inc
07/07/202322h30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PRPOPrecipio Inc
15/06/202323h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRPOPrecipio Inc
14/06/202315h49GlobeNewswire Inc.Precipio’s Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow BiopsyNASDAQ:PRPOPrecipio Inc
13/06/202315h00GlobeNewswire Inc.Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® TechnologyNASDAQ:PRPOPrecipio Inc
09/06/202322h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PRPOPrecipio Inc
08/06/202314h30GlobeNewswire Inc.Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:PRPOPrecipio Inc
 Showing the most relevant articles for your search:NASDAQ:PRPO

Dernières Valeurs Consultées

TSXV
SCS.B
EU
AE15S
Netherlands AEX X15 Shor...
LSE
PAUS
Ivz Usa Esg Acc
ASX
STM
Sunstone Metals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés